FDA Drug Application (203455) for NADOLOL by INVAGEN PHARMS

Back to FDA Applications sponsored by INVAGEN PHARMS

Application Number203455
Product Number001
FormTABLET;ORAL
Dosage20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNADOLOL
Active IngredientNADOLOL

Active IngredientCount
List of drugs with Active Ingredient NADOLOL4


Back to FDA Applications sponsored by INVAGEN PHARMS